These recommendations were finalized by the Task Force in June 1993
| MANEUVER | EFFECTIVENESS | LEVEL OF EVIDENCE <REF> | RECOMMENDATION |
| Screening by abdominal palpation, ultrasound or serologic tumour markers (such as CA19-9 or CA19-9 or elastase-1. | Screening tests have poor yield (CA19-9, CA19-9 plus elastase-1 or ultrasound). Other tests have not been evaluated among asymptomatic individuals. | Cohort studies <8,11-14> (II-2) | There is fair evidence that routine screening should be excluded from the periodic health examination. (D) |
| Evidence that early detection and treatment (surgery or adjuvant therapy) can lower morbidity or mortality is not conclusive. | Randomized controlled trial <6> (I); case- control studies <5,10> (II-2) | ||
| Smoking cessation counselling and follow-up visits. | Smoking cessation strategies are effective. | Randomized controlled trials <15-17> (I) | There is fair evidence that counselling be specifically considered to prevent pancreatic cancer in a periodic health examination. (B)* |
| A modest increase in risk is associated with cigarette smoking. | Cohort and case-control studies <1-3,7,18> (II-2) | ||
| Former smokers have a decreased risk compared to current smokers. | Cohort and case-control studies <2,4,7,9,19> (II-2) |
* There is good evidence to recommend smoking cessation counselling for other reasons (see Chapter 43).
Link to Full Text of this review
Link to Structured Abstract of this review
Link to Selected References list of this review
Reprinted in modified format by the Canadian
Task Force on Preventive Health Care
with permission.
Original Copyright
© 1994 Minister of Supply and Services Canada.
For any technical issues please contact: webmaster@ctfphc.org
Last modified March 27, 1998.
